Revenue Update on Inovalon Holdings Inc(NASDAQ:INOV)

Inovalon Holdings Inc(NASDAQ:INOV) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 3, 2016. Company reported revenue of $123.83M. Analysts estimated a revenue of $126.86M. Earnings per share were $0.14. Analysts had estimated an EPS of $0.14.

Inovalon Holdings Inc (INOV) shares turned negative on Fridays trading session with the shares closing down -0.02 points or -0.14% at a volume of 7,45,815. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $14.77. The peak price level was also seen at $14.77 while the days lowest was $14.54. Finally the shares closed at $14.73. The 52-week high of the shares is $23.87 while the 52-week low is $13.85. According to the latest information available, the market cap of the company is $2,245 M.

Several Insider Transactions has been reported to the SEC. On May 10, 2016, Keith R Dunleavy (CEO) purchased 30,000 shares at $16.39 per share price.Also, On Mar 7, 2016, Robert A Wychulis (President) sold 33,003 shares at $18.17 per share price.On Dec 10, 2015, Daniel L Rizzo (Chief Innovation Officer) sold 24,000 shares at $20.00 per share price, according to the Form-4 filing with the securities and exchange commission.

Inovalon Holdings Inc. is a technology company. The Company combines advanced cloud-based data analytics and data-driven intervention platforms to provide services for health plans hospitals physicians patients pharmaceutical companies and researchers. Through its datasets integration technologies predictive analytics and subject matter expertise the Company delivers platforms. Its analytics identify gaps in care quality data integrity and financial performance while providing clients with capabilities to resolve these gaps. The Company’s data analytics and intervention platforms consist of four primary components: data integration advanced analytics intervention platforms and business processing. This system manages the process of defining and configuring industry data feeds from its clients and partners including electronic health records laboratory pharmacy patient reported claims paper based medical records biometric and hospital data feeds.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Inovalon Holdings Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Inovalon Holdings Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.